Thanks for your insightful imput as always Peter King
Starting to feel this story has a lot more to it and the company is methodically laying out plans for this to explode along with the industry its operating in imo
This is why I am invested
The australian strategy is gaining momentum could it be a matter of months before we get a Aust license ? The company has said its positioning itself to be first mover with this
What will help that cause is their experience with medical cannibis trials in Israel and the associated IP and data , to bring their stated strains to Aust will essentially be helping long sufferers of pain.
Upside in cosmetics , first deal announced last week , must be many more in the wings ? The Australasian market will be big alone . Looking forward to seeing a online shop to get this really moving globally
Given the global scope of growth I assume cornerstone investors are looking at this also
All imo dyor
MXC Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
